A homogeneous interleukin 1 beta (IL-1 beta ), its derivative having a modified amino acid sequence of IL-1 beta , a gene coding for said derivative, medical composition comprising said derivative as a pharmaceutically effective component and a medicinal use of homogeneous IL-1 beta and the derivative.